These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21369496)

  • 21. Ultrasonographic assessment of liquid gastric emptying and antral motility according to the subtypes of irritable bowel syndrome in children.
    Devanarayana NM; Rajindrajith S; Bandara C; Shashiprabha G; Benninga MA
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):443-8. PubMed ID: 23201712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.
    Katsinelos P; Lazaraki G; Kountouras J; Paroutoglou G; Oikonomidou I; Mimidis K; Koutras C; Gelas G; Tziomalos K; Zavos C; Pilpilidis I; Chatzimavroudis G
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):183-9. PubMed ID: 19212207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional bowel disorders in Iranian population using Rome III criteria.
    Sorouri M; Pourhoseingholi MA; Vahedi M; Safaee A; Moghimi-Dehkordi B; Pourhoseingholi A; Habibi M; Zali MR
    Saudi J Gastroenterol; 2010; 16(3):154-60. PubMed ID: 20616409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The current prevalence of irritable bowel syndrome in Asia.
    Chang FY; Lu CL; Chen TS
    J Neurogastroenterol Motil; 2010 Oct; 16(4):389-400. PubMed ID: 21103420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern.
    Heitkemper M; Cain KC; Shulman R; Burr R; Poppe A; Jarrett M
    Dig Dis Sci; 2011 Jul; 56(7):2050-8. PubMed ID: 21290181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher prevalence of joint hypermobility in constipation predominant irritable bowel syndrome.
    Zweig A; Schindler V; Becker AS; van Maren A; Pohl D
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13353. PubMed ID: 29687534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.
    Mearin F; Balboa A; Badía X; Baró E; Caldwell E; Cucala M; Díaz-Rubio M; Fueyo A; Ponce J; Roset M; Talley NJ
    Eur J Gastroenterol Hepatol; 2003 Feb; 15(2):165-72. PubMed ID: 12560761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence of irritable bowel syndrome in Veracruz City, Mexico: a community-based survey].
    Valerio-Ureña J; Vásquez-Fernández F; Jiménez-Pineda A; Cortázar-Benítez LF; Azamar-Jácome AA; Duarte-Velázquez ME; Torres-Medina V
    Rev Gastroenterol Mex; 2010; 75(1):36-41. PubMed ID: 20423781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of irritable bowel syndrome in Hong Kong.
    Kwan AC; Hu WH; Chan YK; Yeung YW; Lai TS; Yuen H
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1180-6. PubMed ID: 12453277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study.
    Koloski NA; Jones M; Young M; Talley NJ
    Aliment Pharmacol Ther; 2015 May; 41(9):856-66. PubMed ID: 25736433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan.
    Kanazawa M; Miwa H; Nakagawa A; Kosako M; Akiho H; Fukudo S
    Biopsychosoc Med; 2016; 10():19. PubMed ID: 27274765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
    Mishima T; Fukae J; Fujioka S; Inoue K; Tsuboi Y
    J Parkinsons Dis; 2017; 7(2):353-357. PubMed ID: 28157108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of functional diarrhea and comparison with diarrhea-predominant irritable bowel syndrome: a population-based survey in China.
    Zhao YF; Guo XJ; Zhang ZS; Ma XQ; Wang R; Yan XY; He J
    PLoS One; 2012; 7(8):e43749. PubMed ID: 22937091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High risk of temporomandibular disorder in irritable bowel syndrome: Is there a correlation with greater illness severity?
    Gallotta S; Bruno V; Catapano S; Mobilio N; Ciacci C; Iovino P
    World J Gastroenterol; 2017 Jan; 23(1):103-109. PubMed ID: 28104985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Features of the course of irritable bowel syndrome in patients with excess body weight].
    Bychkov MA; Ferents IM
    Wiad Lek; 2018; 71(3 pt 2):688-690. PubMed ID: 29783248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome.
    Kawamura Y; Yamamoto S; Funaki Y; Ohashi W; Yamamoto K; Ozeki T; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Ebi M; Ogasawara N; Sasaki M; Kasugai K
    J Gastroenterol; 2020 Jan; 55(1):27-38. PubMed ID: 31428873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An examination of subgroup classification in irritable bowel syndrome patients over time: a prospective study.
    Penny KI; Smith GD; Ramsay D; Steinke DT; Kinnear M; Penman ID
    Int J Nurs Stud; 2008 Dec; 45(12):1715-20. PubMed ID: 18829027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population.
    Mearin F; Badía X; Balboa A; Baró E; Caldwell E; Cucala M; Díaz-Rubio M; Fueyo A; Ponce J; Roset M; Talley NJ
    Scand J Gastroenterol; 2001 Nov; 36(11):1155-61. PubMed ID: 11686214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.